BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.76
EUR
3.37%
Market Closed
Market Cap:
€60.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BRAIN Biotech AG
Other Non-Cash Items
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
BRAIN Biotech AG
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Other Non-Cash Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Other Non-Cash Items
€691.9m
|
CAGR 3-Years
51%
|
CAGR 5-Years
100%
|
CAGR 10-Years
13%
|
|
|
Evonik Industries AG
XETRA:EVK
|
Other Non-Cash Items
-€3m
|
CAGR 3-Years
64%
|
CAGR 5-Years
38%
|
CAGR 10-Years
31%
|
|
|
Covestro AG
XETRA:1COV
|
Other Non-Cash Items
€257m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
|
AlzChem Group AG
XETRA:ACT
|
Other Non-Cash Items
€66.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Other Non-Cash Items
€484.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
23%
|
CAGR 10-Years
15%
|
|
No Stocks Found
BRAIN Biotech AG
Glance View
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.
BNN
Intrinsic Value
2.41
EUR
Overvaluation 13%
